Sanofi resumes production after replacing supplier
This article was originally published in The Gold Sheet
Executive Summary
Sanofi-Aventis expected to bring single-dose vials of its YF-VAX yellow fever vaccine back to market this month after validating a new supplier for the specialized production equipment required to insert the vaccine into single-dose vials, the Centers for Disease Control and Prevention said Jan. 19. The previous supplier had gone out of business
You may also be interested in...
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.